accessibility menu, dialog, popup

UserName

Antracykliner

Organiska föreningar karakteriserade som antracenderivat och kända för deras användning i cancerkemoterapi; de extraheras vanligtvis från Streptomyces-bakterien.
Molekylvikt (g/mol) 
  • (4)
  • (2)
  • (3)
  • (3)
  • (14)
  • (3)
  • (1)
Kvantitet 
  • (3)
  • (7)
  • (1)
  • (1)
  • (2)
  • (5)
  • (5)
  • (6)
Procent renhet 
  • (6)
Fysisk form 
  • (4)

Filtrerade sökresultat

Produkter från vissa av våra leverantörer visas inte i filtrerade sökresultat. Vänligen Rensa alla filter för att se dessa produkter.

Begränsa resultat

Begränsa resultat

Kategori

Specialerbjudande

  • (3)

Varumärken

  • (4)
  • (4)
  • (22)

Molekylvikt (g/mol)

  • (4)
  • (2)
  • (3)
  • (3)
  • (14)
  • (3)
  • (1)

Kvantitet

  • (3)
  • (7)
  • (1)
  • (1)
  • (2)
  • (5)
  • (5)
  • (6)

Procent renhet

  • (6)

Fysisk form

  • (4)
Sök på nyckelord:
1 – 11 av 11 Resultat
1
Kampanjer är tillgängliga

Doxorubicin hydroklorid, MP Biomedicals™

CAS: 25316-40-9 Molekylformel: C27H30ClNO11 Molekylvikt (g/mol): 579.98 MDL-nummer: MFCD00077757,MFCD00077757,MFCD00941448 InChI-nyckel: MWWSFMDVAYGXBV-FGBJBKNOSA-N Synonym: doxorubicin hydrochloride,adriamycin,doxorubicin hcl,adriacin,adriblastina,rubex,adriamycin hydrochloride,adriblastin,adriamycin pfs PubChem CID: 129626538 IUPAC-namn: väte (8S,10S)-10-[(4-amino-5-hydroxi-6-metyloxan-2-yl)oxi]-6,8,11-trihydroxi-8-(2-hydroxiacetyl)-1-metoxi-5,7,8,9,10,12-hexahydrotetracen-5,12-dionklorid LEDER: [H+].[Cl-].COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3OC3CC(N)C(O)C(C)O3)C(=O)CO)C(O)=C1C2=O

Molekylformel C27H30ClNO11
PubChem CID 129626538
MDL-nummer MFCD00077757,MFCD00077757,MFCD00941448
IUPAC-namn väte (8S,10S)-10-[(4-amino-5-hydroxi-6-metyloxan-2-yl)oxi]-6,8,11-trihydroxi-8-(2-hydroxiacetyl)-1-metoxi-5,7,8,9,10,12-hexahydrotetracen-5,12-dionklorid
CAS 25316-40-9
InChI-nyckel MWWSFMDVAYGXBV-FGBJBKNOSA-N
LEDER [H+].[Cl-].COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3OC3CC(N)C(O)C(C)O3)C(=O)CO)C(O)=C1C2=O
Molekylvikt (g/mol) 579.98
Synonym doxorubicin hydrochloride,adriamycin,doxorubicin hcl,adriacin,adriblastina,rubex,adriamycin hydrochloride,adriblastin,adriamycin pfs
2

Daunorubicinol Hydrochloride (Mixture of Diastereomers), TRC

CAS: 28008-53-9 Molekylformel: C27 H31 N O10 . Cl H Molekylvikt (g/mol): 566

Molekylformel C27 H31 N O10 . Cl H
CAS 28008-53-9
Molekylvikt (g/mol) 566
3

Daunorubicin Hydrochloride, TRC

CAS: 23541-50-6 Molekylformel: C27 H29 N O10 . Cl H Molekylvikt (g/mol): 563.98 Synonym: Daunorubicin hydrochloride,(8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride,5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride (1:1), (8S,10S)-,5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)- (9CI),5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-,Daunomycin, hydrochloride (8CI),Cerubidine,Daunoblastin,Daunomycin chlorohydrate,NDC 0082-4155,Ondena,RP 13057 hydrochloride,Rubidomycin hydrochloride IUPAC-namn: (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride LEDER: Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)C

Molekylformel C27 H29 N O10 . Cl H
IUPAC-namn (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
CAS 23541-50-6
LEDER Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)C
Molekylvikt (g/mol) 563.98
Synonym Daunorubicin hydrochloride,(8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride,5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride (1:1), (8S,10S)-,5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)- (9CI),5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-,Daunomycin, hydrochloride (8CI),Cerubidine,Daunoblastin,Daunomycin chlorohydrate,NDC 0082-4155,Ondena,RP 13057 hydrochloride,Rubidomycin hydrochloride
4

Idarubicin Hydrochloride (1 mg/mL in DMSO), TRC

High-purity organic molecules and analytical standards, strategically delivered worldwide to empower innovation and commercial success.

5

Pirarubicin, TRC

CAS: 72496-41-4 Molekylformel: C32 H37 N O12 Molekylvikt (g/mol): 627.64 Synonym: 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-,5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, [8S-[8α,10α(S*)]]-,5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)- (9CI),(8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione,(2' 'R)-4'-O-Tetrahydropyranyladriamycin,(2' 'R)-4'-O-Tetrahydropyranyldoxorubicin,4'-O-Tetrahydropyranyladriamycin,Pinorubicin,Pirarubicin,THP-Adriamycin,Therarubicin IUPAC-namn: (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione LEDER: COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO

Molekylformel C32 H37 N O12
IUPAC-namn (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
CAS 72496-41-4
LEDER COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO
Molekylvikt (g/mol) 627.64
Synonym 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-,5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, [8S-[8α,10α(S*)]]-,5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)- (9CI),(8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione,(2' 'R)-4'-O-Tetrahydropyranyladriamycin,(2' 'R)-4'-O-Tetrahydropyranyldoxorubicin,4'-O-Tetrahydropyranyladriamycin,Pinorubicin,Pirarubicin,THP-Adriamycin,Therarubicin
6

Doxorubicin Hydrochloride, TRC

CAS: 25316-40-9 Molekylformel: C27 H29 N O11 . Cl H Molekylvikt (g/mol): 579.98 Synonym: Doxorubicin Hydrochloride,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI),5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-,Adriamycin, hydrochloride (8CI),2B 3-101,ADM hydrochloride,ADR,Adriablastina CS,Adriacin,Adriamycin,Adriblastin,Adriblastina,Adriblastina RD,Adrosal,Ameisu hydrochloride,Caelyx pegylated liposomal,DOX HCl,Doxolipad,Doxorubicin hydrochloride,Doxorubicin-LANS,Doxorubicin-TEVA,FI 106,FI 6804,Hydroxydaunorubicin hydrochloride,Lipo-Dox,Myocet liposoma,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)- IUPAC-namn: (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride LEDER: Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO

Molekylformel C27 H29 N O11 . Cl H
IUPAC-namn (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
CAS 25316-40-9
LEDER Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO
Molekylvikt (g/mol) 579.98
Synonym Doxorubicin Hydrochloride,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI),5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-,Adriamycin, hydrochloride (8CI),2B 3-101,ADM hydrochloride,ADR,Adriablastina CS,Adriacin,Adriamycin,Adriblastin,Adriblastina,Adriblastina RD,Adrosal,Ameisu hydrochloride,Caelyx pegylated liposomal,DOX HCl,Doxolipad,Doxorubicin hydrochloride,Doxorubicin-LANS,Doxorubicin-TEVA,FI 106,FI 6804,Hydroxydaunorubicin hydrochloride,Lipo-Dox,Myocet liposoma,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-
7

Doxorubicinol (>90%), TRC

CAS: 54193-28-1 Molekylformel: C27 H31 N O11 Molekylvikt (g/mol): 545.54 Synonym: 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, [8S-[8α,8(R*),10α]]-,(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione,13-Dihydrodoxorubicin,Adriamycinol,Antibiotic 27706RP,Doxorubicinol,RP 27706 IUPAC-namn: (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-[(1S)-1,2-dihydroxyethyl]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione LEDER: COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)[C@@H](O)CO

Molekylformel C27 H31 N O11
IUPAC-namn (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-[(1S)-1,2-dihydroxyethyl]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
CAS 54193-28-1
LEDER COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)[C@@H](O)CO
Molekylvikt (g/mol) 545.54
Synonym 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, [8S-[8α,8(R*),10α]]-,(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione,13-Dihydrodoxorubicin,Adriamycinol,Antibiotic 27706RP,Doxorubicinol,RP 27706
8

Idarubicin Hydrochloride, TRC

CAS: 57852-57-0 Molekylformel: C26 H27 N O9 . Cl H Molekylvikt (g/mol): 533.95 Synonym: (7S,9S)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione Hydrochloride (1:1),5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S,9S)- (9CI),5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S-cis)-,4-DMD HCl,4-Demethoxydaunorubicin hydrochloride,Idamycin,Idarubicin hydrochloride,NSC 256439,Zavedos IUPAC-namn: (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride LEDER: Cl.C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5ccccc5C(=O)c4c(O)c23)C(=O)C

Molekylformel C26 H27 N O9 . Cl H
IUPAC-namn (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
CAS 57852-57-0
LEDER Cl.C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5ccccc5C(=O)c4c(O)c23)C(=O)C
Molekylvikt (g/mol) 533.95
Synonym (7S,9S)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione Hydrochloride (1:1),5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S,9S)- (9CI),5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S-cis)-,4-DMD HCl,4-Demethoxydaunorubicin hydrochloride,Idamycin,Idarubicin hydrochloride,NSC 256439,Zavedos
9

Epirubicin Hydrochloride, TRC

CAS: 56390-09-1 Molekylformel: C27 H29 N O11 . Cl H Molekylvikt (g/mol): 579.98 Synonym: (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-l-arabino-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI),5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-,4'-Epidoxorubicin hydrochloride,4'-epi-Adriamycin hydrochloride,Ellence,Epidoxorubicin hydrochloride,Epirubicin hydrochloride,Farmorubicin,Pharmorubicin IUPAC-namn: (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride LEDER: Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO

Molekylformel C27 H29 N O11 . Cl H
IUPAC-namn (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
CAS 56390-09-1
LEDER Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO
Molekylvikt (g/mol) 579.98
Synonym (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-l-arabino-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-,5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI),5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-,4'-Epidoxorubicin hydrochloride,4'-epi-Adriamycin hydrochloride,Ellence,Epidoxorubicin hydrochloride,Epirubicin hydrochloride,Farmorubicin,Pharmorubicin
11

Doxorubicin Hydrochloride, Fisher BioReagents

CAS: 25316-40-9 Molekylformel: C27H30ClNO11 Molekylvikt (g/mol): 579.98 MDL-nummer: MFCD00077757,MFCD00077757,MFCD00941448 InChI-nyckel: MWWSFMDVAYGXBV-FGBJBKNOSA-N Synonym: doxorubicin hydrochloride,adriamycin,doxorubicin hcl,adriacin,adriblastina,rubex,adriamycin hydrochloride,adriblastin,adriamycin pfs PubChem CID: 129626538 IUPAC-namn: (7R,9R)-7-[(2S,4R,5R,6R)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride LEDER: [H+].[Cl-].COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3OC3CC(N)C(O)C(C)O3)C(=O)CO)C(O)=C1C2=O

Molekylformel C27H30ClNO11
PubChem CID 129626538
MDL-nummer MFCD00077757,MFCD00077757,MFCD00941448
IUPAC-namn (7R,9R)-7-[(2S,4R,5R,6R)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
CAS 25316-40-9
InChI-nyckel MWWSFMDVAYGXBV-FGBJBKNOSA-N
LEDER [H+].[Cl-].COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3OC3CC(N)C(O)C(C)O3)C(=O)CO)C(O)=C1C2=O
Molekylvikt (g/mol) 579.98
Synonym doxorubicin hydrochloride,adriamycin,doxorubicin hcl,adriacin,adriblastina,rubex,adriamycin hydrochloride,adriblastin,adriamycin pfs